
Nano-X Imaging Ltd
NASDAQ:NNOX

Net Margin
Nano-X Imaging Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
IL |
![]() |
Nano-X Imaging Ltd
NASDAQ:NNOX
|
312.1m USD |
-476%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
223.6B USD |
32%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
179.3B USD |
29%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
157.4B USD |
14%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
153.3B USD |
12%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
118.1B USD |
14%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
55.2B EUR |
9%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
52.2B USD |
7%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
47.6B USD |
73%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.4B USD |
23%
|
|
US |
![]() |
Resmed Inc
NYSE:RMD
|
40.6B USD |
26%
|
Nano-X Imaging Ltd
Glance View

See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Nano-X Imaging Ltd's most recent financial statements, the company has Net Margin of -475.9%.